Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 study.
Journal: Blood vessels, thrombosis & hemostasis
Published: December 08, 2025
Plain Language Summary on Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa-PROTECT Main Study.
Journal: European journal of haematology
Published: November 28, 2025
Treatment of Haemophilia A Without Inhibitors: Real-World Treatment Patterns and Clinical Outcomes in the US.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: September 18, 2025
Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa-PROTECT Main Study.
Journal: European journal of haematology
Published: July 18, 2025
Current practices in pediatric hospital-acquired thromboembolism: Survey of the Children's Hospital Acquired Thrombosis (CHAT) Consortium.
Journal: Research and practice in thrombosis and haemostasis
Published: April 20, 2022
Thromboelastographic characterization of the activated clotting system in children with sickle cell trait or sickle cell disease.
Journal: Thrombosis research
Published: July 17, 2016
A novel missense mutation in the FGB gene (p.Gly302Arg) leading to afibrinogenemia. Predicted structure and function consequences.
Journal: Hamostaseologie
Published: March 17, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026